Conversion of acyclic nonpeptide CCK antagonists into CCK agonists
- 4 March 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (5) , 511-514
- https://doi.org/10.1016/s0960-894x(97)00062-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A Agonists That Demonstrate Oral Activity as Satiety AgentsJournal of Medicinal Chemistry, 1996
- Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”Journal of Medicinal Chemistry, 1996
- Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity (II): Optimization of the C3 Amino SubstituentJournal of Medicinal Chemistry, 1996
- Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonistsEuropean Journal of Pharmacology, 1994
- Biological actions of cholecystokininPeptides, 1994
- Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718Journal of Medicinal Chemistry, 1992
- Novel glutamic acid-derived cholecystokinin receptor ligandsJournal of Medicinal Chemistry, 1990
- Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonistsJournal of Medicinal Chemistry, 1989